US5660999A - P0438, a new calcium-regulated promoter - Google Patents

P0438, a new calcium-regulated promoter Download PDF

Info

Publication number
US5660999A
US5660999A US08/264,526 US26452694A US5660999A US 5660999 A US5660999 A US 5660999A US 26452694 A US26452694 A US 26452694A US 5660999 A US5660999 A US 5660999A
Authority
US
United States
Prior art keywords
streptomyces
promoter
gene
sequence
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/264,526
Inventor
AntonioDaza Ortega
Jose Antonio Gil
Tomas Vigal Garcia
Juan Francisco Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SA
Original Assignee
Laboratoires Serono SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono SA filed Critical Laboratoires Serono SA
Priority to US08/264,526 priority Critical patent/US5660999A/en
Application granted granted Critical
Publication of US5660999A publication Critical patent/US5660999A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/11Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11)
    • C12Y113/11001Catechol 1,2-dioxygenase (1.13.11.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y113/00Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/11Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11)
    • C12Y113/11002Catechol 2,3-dioxygenase (1.13.11.2)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Definitions

  • the invention is in the field of biotechnology. More particularly, it relates to a new calcium-regulated promoter to be used for increasing production of extracellular enzymes, or heterologous polypeptides, a recombinant vector that includes the DNA sequence of the promoter operatively linked to a DNA encoding said enzyme or polypeptide and a host organism transformed with the recombinant vector that includes the promoter operatively linked to the DNA encoding said enzyme or polypeptide.
  • the present invention further relates to Streptomyces expression systems and methods for expressing foreign DNA sequences in Streptomyces and for secreting to the surrounding medium polypeptides and proteins coded for by those foreign DNA sequences.
  • The-Streptomyces are well known producers of a variety of extracellular enzymes including proteases, phosphatases, xylanases, cellulases, amylases, lipases and nucleases.
  • members of the genus Streptomyces produce a large number of antibiotics, pigments and other secondary metabolites and have a complex pattern of differentiation resulting in the formation of spores.
  • Streptomyces there is usually a coincidence in the production of extracellular enzymes and the onset of antibiotic production and pigment biosynthesis and sporulation. All of these processes are repressed by nutritional conditions favoring high growth rates and are derepressed by starvation of P, C or N sources. It is unlikely that enzyme secretion, formation of secondary metabolites and differentiation are completely independent but respond to similar triggering mechanisms.
  • Streptomyces encoding extracellular enzymes have keen cloned. These include agarase from Streptomyces coelicolor, endoglycosidase H from Streptomyces plicatus, xylanases from Streptomyces lividans, alpha-amylase from Streptomyces hygroscopius, cellulase from Strep. spA2, beta-gaiactosidase from Strep. lividans and beta-lactamases from Strep. cacaoi, badius and fradiae.
  • Positive regulatory genes affecting enzyme synthesis and/or secretion can be cloned by searching for increased secretion of extracellular enzymes in a poor secretory strain such as S. lividans.
  • the promoter of the saf gene has been found to be more potent: than natural promoter of extracellular enzymes.
  • the amylase gene expresses much greater quantities of amylase when the saf promoter is substituted with the natural amylase promoter.
  • the saf promoter can be used to enhance the expression of any endogenous polypeptide or protein in place of that protein's natural promoter.
  • plasmid pIJ702 (Katz et el., J. GEN. MICROBIOL. 129:2703-2714, 1983) was used as a cloning vector.
  • This plasmid contains the gene of tyrosinase, the enzyme responsible for the formation of melamin from tryosine in several species of Streptomyces.
  • ORFs open reading frames
  • fragment SstI-KpnI (432 nucleotides--saf gene without promoter) was inserted into the BglII site of pIJ702.
  • a surprising aspect of the study was the lack of expression of this fragment when inserted with the right orientation and its expression when inserted with the opposite direction (clockwise direction) to ORF438. This finding implied the presence of a fragment with promoter activity, before the gene mel and at the BglII cloning site, located within the ORF438, with opposite orientation.
  • a principal object of this invention is to provide a new promoter which has been identified in a DNA fragment contained within the ORF438 of pIJ702 plasmid.
  • the promoter activity is positively regulated by calcium ions and expression of the genes for extracellular enzymes in Streptomyces, operatively linked to said promoter, is greatly increased in the presence of CaCl 2 solutions.
  • vectors which include said promoter operatively linked to an endogenous or foreign DNA sequence encoding a polypeptide or protein, as well as host organisms or cells transformed with such cloning vehicles, thereby resulting in expression and secretion of the polypeptide encoded by said DNA sequence.
  • Another aspect of the present invention is the integration of such a cloning vehicle carrying a foreign DNA sequence into the chromosomal DNA of Streptomyces.
  • the new promoter contained in the ORF438 shows promoter activity in opposite orientation to that of the ORF438 and is hereinafter referred to as Po438 (Promoter opposite to the ORF438).
  • Po438 Promoter opposite to the ORF438.
  • the knowledge of its clockwise promoter activity in pIJ702 is very important so as to avoid erroneous interpretations in gene expression studies of DNA fragments cloned in this vector.
  • the Po438 promoter is the first known calcium-regulated promoter that has been characterized in Streptomyces and can be used to enhance expression in Streptomyces of selected heterologous proteins by inserting the DNA fragment containing the Po438 promoter into a suitable cleavage site upstream of the gene coding for the desired protein in a suitable cloning vehicle, transforming a Streptomyces host with such cloning vehicles and culturing the transformed bacteria in the presence of a Ca 2+ solution to excrete the selected protein or portion thereof.
  • the promoter activity of Po438 has been detected using two different promoter-probe vectors.
  • the DNA fragment containing the Po438 promoter was subcloned in two different plasmids carrying the promoterless aminoglycoside phosphotransferase gene (neo) and the promoterless catechol dioxygenase gene (XylE) respectively (FIG. 1). Both genes expressed great quantities of each enzyme in the presence of increasing concentrations of calcium ions, thus indicating the calcium-regulated promoter activity of Po438.
  • the transcription start point in Po438 was determined through a S1 nuclease mapping experiment, which situated the start point around the C at 24 nt from the SstI site (FIG. 4).
  • FIG. 1 Construction of plasmids pULAD50 and pULAD51 carrying the 242 bp SstI-BglII fragment of pIJ702 (containing Po438) cloned in the promoter-probe vectors pIJ487 (Ward et al., 1986) and pIJ4083.
  • FIG. 2 Promoter activity of the 242 bp SstI-B1II fragment pIJ702.
  • a kanamycin gradient (o-180 ug/ml) was established on solid MM medium (Hopwood, 1967) and was streaked with S. lividans carrying the plasmid pULAD50 (A) or pIJ487 (B).
  • FIG. 3 Schematic representation of a region of pULAD50 carrying the 242 bp SstI-BglII fragment of piJ702 and strategy followed for S1 mapping in the diagram the bar marked with asterisk represents the labeled fragment, and the bar with S1 represents the protected fragment obtained.
  • Lanes A-C-G-T show the four sequence reactions for the M13mp18 single strand DNA (right) and for the 242 bp SstI-BglII fragment from pIJ702 (left).
  • The-arrowheads indicate the hybridization bands corresponding to the protected fragments.
  • FIG. 4 Nucleotide sequence (SEQ ID NO.1) of the DNA region in the mel. cluster that contains the ORF438 indicating its amino acid sequence.
  • the BglII and SStI restriction sites which flank the DNA fragment cloned in pIJ487 to construct pULAD50 are indicated.
  • the two first amino acids of the tyrosinase are also shown.
  • FIG. 5 Phosphate repression of expression from the Po438 promoter.
  • a neomycin gradient (0-180 ug/ml) was made on solid MM+TES buffer 825 mM, pH 7.2) (upper plate), and on the same medium supplemented with 20 MM sodium phosphate buffer, pH 7.2 (lower plate). Both plates were streaked with a similar amount of S. lividans [pULAD50] spores.
  • FIG. 6 Calcium induction in Streptomyces of the promoterless XylE gene of Pseudomonas putida when placed downstream of the Po438 promoter.
  • S. lividans [pULAD51] was grown in calcium-free R2YE liquid medium ( ⁇ ) and R2YE medium supplemented with additional CaCl 2 up to 60 mM (66 ).
  • Catechol dioxygenase activity (Cat O 2 ase) of S. lividans transformed with pIJ4083 ( ⁇ ) was not altered when grown in R2YE medium with or without CaCl 2 .
  • Plasmid DNA was isolated following the Kieser method (Kieser et el., PLASMID 12:19-36, 1984). Digestions and ligations were monitored by agarose gel electrophoresis. The conditions for digestion with a restriction endonuclease and ligation reactions were those recommended by the manufacturers. Subcloning of DNA fragments was carried out by digesting 1-2, ug of plasmid DNA with adequate restriction enzyme(s) and the reaction products were separated by gel electrophoresis in low melting point agarose (LMPA).
  • LMPA low melting point agarose
  • the nucleotide sequence was determined by the chain termination method of Sanger (Sanger et al., PROC. NATL. ACAD. SCI. USA 74:5463-5467, 1977) using M13 clones (Messing et al., NUCL. ACIDS RES. 9:309-321, 1981).
  • RNA isolation and S1 nuclease mapping were carried out at 60° C.
  • the promoter activity of Po438 has been determined through the expression of the aminoglycoside phosphotransferase gene and the catechol dioxygenase gene contained in two different promoter-probe vectors.
  • Lividans transformed with pULAD50 was able to grow on MM containing more than 150 ug/ml of Km, whereas S. lividans transformed with pIJ487 (promoter-probe vector without inserted promoter) does not grow on MM with 10 ug/ml Km as shown in FIG. 2.
  • This result clearly indicates that the BglII-SstI fragment of pIJ70 has promoter activity in Streptomyces, with orientation from the SStI site to the BglII site.
  • the 242 bpBgl BglII-SstI fragment as in the above example wa subcloned into a different promoter-probe vector, the plasmid pIJ4083 which carried the XylE gene from Pseudomonas putida, coding for the enzyme catechol dioxygenase.
  • the hybrid plasmid was named pULAD51 (FIG. 1). Streptomyces lividans transformed with pULAD51 was grown in R2YE medium supplemented with CaCl 2 up to 60 Mm. Quantitation of Catechol dioxygenase activity indicated that Po438 exerts promoter activity also when inserted upstream of the XylE gene (FIG. 6).
  • Neomycin was used in MM for these studies. In all cases MM was supplemented with TES buffer (25 mM, pH 7.2) in order to avoid pH changes.
  • Mg 2+ , Fe 2+ , Zn 2+ , Cu 2+ cations had no effect on the strength of Po438 (resistance to 170 ug/ml Neo on MM plates), whereas several monovalent cations (Na + , K + , Li + , Cs + , 10 mM) exerted a weak reduction of the promoter activity and there was no growth on MM containing more than 100 ug/ml of Neo. A reduction in promoter activity-was also observed when the MM was supplemented with sodium phosphate buffer (20 mM, pH 7.2) as shown in FIG. 5.
  • Plasmid pULAD60 represents an example of a similar plasmid with the same neo-gene linked to a different promoter, the saf promoter, as has been described in WO 90/14426.
  • the Neo resistance of S. lividans transformed with pULAD60 was not, however, modified when growing on MM containing different concentrations of CaCl 2 (0, 10, 20, 30, 40 mM), suggesting that there is not a post-translational stimulation of the neo gene product, nor a calcium inactivation of Neomycin. If the effect of Ca 2+ were not specific, the stimulating effect should be observed with all the constructions. This demonstrates that the Po438 promoter activity is specifically regulated by calcium ions.
  • the 242 bp BglII-SstI fragment of pIJ702 was used as a probe.
  • the fragment was labelled in the BglII 5' end and hybridized with mRNA isolated from s. lividans transformed with pIJ702.
  • FIG. 3 shows that the protected fragment was still 24 nt shorter than the probe, indicating that the transcription initiation occurs in pIJ702 in a similar nucleotide as in pULAD50.
  • FIG. 4 shows the promoter region of the mel gene in ORF 438, located about 30 nt upstream from the start codon of the ORF 438 (Geistlich et. al., Molecular Microbiology 3: 1061-1069, 1989; Leu et al., GENE 84:267-277, 1989) as well as the Po438 promoter located in opposite orientation to that of ORF 438 and its transcription start point according to the S1 nuclease mapping experiments of this work.
  • the aminoglycoside phosphtransferase gene and the catechol dioxygenase gene have been specifically exemplified, it should be understood that for the purpose of enhancing expression through the use of the Po438 promoter, the gene for any polypeptide or protein produced by the Streptomyces species being used can be modified by removing the native promoter and substituting the Po438 promoter. Similarly, the foreign DNA coding for a polypeptide or protein can be inserted into any such endogenous gene. Preferably, however, the endogenous gene selected will be one which expresses the protein through the cell wall and into the culture medium, in which case, it is important to retain the secretion signal sequence.
  • the foreign DNA is thus preferably inserted in such a way as to retain the secretion signals as much as possible from the extracellular enzyme gene. While these signals are predominantly on the leader sequence, there is evidence with respect to endogenous genes for extracellular enzymes that the terminal carboxyl end is also important for secretion. Thus, it may be best to create a fusion protein by inserting the foreign DNA into the endogenous DNA, rather than removing the transcriptional part of the endogenous DNA and substituting the foreign DNA.
  • the foreign DNA sequence may be any non-Streptomyces-derived DNA sequence encoding a protein or polypeptide, particularly one of eukaryotic or viral origin.
  • eukaryotic and viral DNA sequences are sequences encoding human and animal leukocyte interferons (IFN-alpha), fibrobtast interferons (IFN-beta), and immune interferons (IFN-gamma), human insulin, human and animal growth and other hormones, such as corticotropin releasing factor (CRF), human serum albumin and various human blood factors and plasmignogen activators, both tissue and urokinase, hepatitis B viral core and surface antigens, FMD viral antigens and other human animal and viral polypeptides and proteins.
  • IFN-alpha human and animal leukocyte interferons
  • IFN-beta fibrobtast interferons
  • IFN-gamma immune interferons
  • human insulin human and animal growth and other
  • KATZ E., Thompson, C. J. and Hopwood, D. A.: Cloning and expression of the tyrosinase gene from Streptomyces antibioticus in Streptomyces lividans. J. Gen. Microbiol. 129 (1983) 2703-2714.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)

Abstract

There is disclosed a new calcium-regulated promoter to be used for increasing production of extracellular enzymes, or heterologous polypeptide, a recombinant vector that includes the DNA sequence of the promoter operatively linked to a DNA encoding said enzyme or polypeptide and a host organism transformed with the recombinant vector that includes the promoter operatively linked to the DNA encoding said enzyme or polypeptide. The present invention further relates to Streptomyces expression systems and methods for expressing foreign DNA sequences in Streptomyces and for secreting to the surrounding medium polypeptides and proteins coded for by those foreign DNA sequences.

Description

This is a division of application Ser. No. 07/989,363, filed Dec. 11, 1992, U.S. Pat. No. 5,385,841.
The invention is in the field of biotechnology. More particularly, it relates to a new calcium-regulated promoter to be used for increasing production of extracellular enzymes, or heterologous polypeptides, a recombinant vector that includes the DNA sequence of the promoter operatively linked to a DNA encoding said enzyme or polypeptide and a host organism transformed with the recombinant vector that includes the promoter operatively linked to the DNA encoding said enzyme or polypeptide. The present invention further relates to Streptomyces expression systems and methods for expressing foreign DNA sequences in Streptomyces and for secreting to the surrounding medium polypeptides and proteins coded for by those foreign DNA sequences.
The-Streptomyces are well known producers of a variety of extracellular enzymes including proteases, phosphatases, xylanases, cellulases, amylases, lipases and nucleases.
In addition, members of the genus Streptomyces produce a large number of antibiotics, pigments and other secondary metabolites and have a complex pattern of differentiation resulting in the formation of spores. In batch cultures of Streptomyces there is usually a coincidence in the production of extracellular enzymes and the onset of antibiotic production and pigment biosynthesis and sporulation. All of these processes are repressed by nutritional conditions favoring high growth rates and are derepressed by starvation of P, C or N sources. It is unlikely that enzyme secretion, formation of secondary metabolites and differentiation are completely independent but respond to similar triggering mechanisms.
Several genes of Streptomyces encoding extracellular enzymes have keen cloned. These include agarase from Streptomyces coelicolor, endoglycosidase H from Streptomyces plicatus, xylanases from Streptomyces lividans, alpha-amylase from Streptomyces hygroscopius, cellulase from Strep. spA2, beta-gaiactosidase from Strep. lividans and beta-lactamases from Strep. cacaoi, badius and fradiae.
However, the regulatory mechanisms which control expression of these genes are virtually unknown. In addition to specific regulatory mechanisms, such as induction of amylase by dextrins or meltotriose and carbon metabolite regulation of amylase or agarase, general mechanisms of derepression of several extracellular enzymes are likely to occur since simultaneous production of several polymeric-substrate degrading enzymes has been observed in Streptomyces following a nutritional down-shift. Such transacting regulatory genes have been found in Bacillus subtilis (J. BACTERIOL. 169:324-333, 1987), Bacillus natto (J. BACTEROL. 166:20-28, 1986), and Bacillus licheniformis.
Positive regulatory genes affecting enzyme synthesis and/or secretion can be cloned by searching for increased secretion of extracellular enzymes in a poor secretory strain such as S. lividans.
Systems for expressing foreign DNA sequences in Streptomyces have previously been described in, for example, EP 148,552 and WO 88/07079. These systems use the endogenous promoters of extracellular enzymes produced by Streptomyces.
The substitution of the endogenous promoters with foreign promoters has been disclosed in WO 90/14426 which describes the cloning and characterization of a newly isolated gene, the saf gene, encoding a new polypeptide, referred to as saf polypeptide, which modulates directly, or indirectly, expression of the genes for extracellular enzymes in Streptomyces by interacting with the control region of the structural genes for the extracellular enzymes.
The promoter of the saf gene has been found to be more potent: than natural promoter of extracellular enzymes. For example, the amylase gene expresses much greater quantities of amylase when the saf promoter is substituted with the natural amylase promoter. Thus, the saf promoter can be used to enhance the expression of any endogenous polypeptide or protein in place of that protein's natural promoter.
For the cloning and characterization of the saf gene, plasmid pIJ702 (Katz et el., J. GEN. MICROBIOL. 129:2703-2714, 1983) was used as a cloning vector. This plasmid contains the gene of tyrosinase, the enzyme responsible for the formation of melamin from tryosine in several species of Streptomyces. The mel locus in pIJ702 has been sequenced and two open reading frames (ORFs) have been identified: the first is the ORF corresponding to the mel gene that codes for the polypeptide chain of tyrosinase, the second ORF, located upstream of the mel gene, was named ORF438 (Bernan et at., GENE 37:101-110, 1985) and its role is yet unclear.
During the study carried out to locate precisely the saf gene, fragment SstI-KpnI (432 nucleotides--saf gene without promoter) was inserted into the BglII site of pIJ702. A surprising aspect of the study was the lack of expression of this fragment when inserted with the right orientation and its expression when inserted with the opposite direction (clockwise direction) to ORF438. This finding implied the presence of a fragment with promoter activity, before the gene mel and at the BglII cloning site, located within the ORF438, with opposite orientation.
A principal object of this invention is to provide a new promoter which has been identified in a DNA fragment contained within the ORF438 of pIJ702 plasmid. The promoter activity is positively regulated by calcium ions and expression of the genes for extracellular enzymes in Streptomyces, operatively linked to said promoter, is greatly increased in the presence of CaCl2 solutions.
It is another aspect of the present invention to provide cloning vehicles (vectors) which include said promoter operatively linked to an endogenous or foreign DNA sequence encoding a polypeptide or protein, as well as host organisms or cells transformed with such cloning vehicles, thereby resulting in expression and secretion of the polypeptide encoded by said DNA sequence.
Another aspect of the present invention is the integration of such a cloning vehicle carrying a foreign DNA sequence into the chromosomal DNA of Streptomyces.
It is yet another aspect of the present invention a process for the preparation of an extracellular enzyme, a desired polypeptide or protein by culturing a transformed host organism according to the present invention and recovering the product from the culture broth.
The new promoter contained in the ORF438 shows promoter activity in opposite orientation to that of the ORF438 and is hereinafter referred to as Po438 (Promoter opposite to the ORF438). The knowledge of its clockwise promoter activity in pIJ702 is very important so as to avoid erroneous interpretations in gene expression studies of DNA fragments cloned in this vector.
The Po438 promoter is the first known calcium-regulated promoter that has been characterized in Streptomyces and can be used to enhance expression in Streptomyces of selected heterologous proteins by inserting the DNA fragment containing the Po438 promoter into a suitable cleavage site upstream of the gene coding for the desired protein in a suitable cloning vehicle, transforming a Streptomyces host with such cloning vehicles and culturing the transformed bacteria in the presence of a Ca2+ solution to excrete the selected protein or portion thereof.
The promoter activity of Po438 has been detected using two different promoter-probe vectors. The DNA fragment containing the Po438 promoter was subcloned in two different plasmids carrying the promoterless aminoglycoside phosphotransferase gene (neo) and the promoterless catechol dioxygenase gene (XylE) respectively (FIG. 1). Both genes expressed great quantities of each enzyme in the presence of increasing concentrations of calcium ions, thus indicating the calcium-regulated promoter activity of Po438.
The transcription start point in Po438 was determined through a S1 nuclease mapping experiment, which situated the start point around the C at 24 nt from the SstI site (FIG. 4).
Referring to the accompanying drawings.
FIG. 1 Construction of plasmids pULAD50 and pULAD51 carrying the 242 bp SstI-BglII fragment of pIJ702 (containing Po438) cloned in the promoter-probe vectors pIJ487 (Ward et al., 1986) and pIJ4083.
FIG. 2 Promoter activity of the 242 bp SstI-B1II fragment pIJ702. A kanamycin gradient (o-180 ug/ml) was established on solid MM medium (Hopwood, 1967) and was streaked with S. lividans carrying the plasmid pULAD50 (A) or pIJ487 (B).
FIG. 3 Schematic representation of a region of pULAD50 carrying the 242 bp SstI-BglII fragment of piJ702 and strategy followed for S1 mapping in the diagram the bar marked with asterisk represents the labeled fragment, and the bar with S1 represents the protected fragment obtained. Lanes A-C-G-T show the four sequence reactions for the M13mp18 single strand DNA (right) and for the 242 bp SstI-BglII fragment from pIJ702 (left).
1 Protected fragment in the hybridization between the 270 nt HindIII-SstI fragment of pULAD50 and mRNA from S. lividans [pULAD50].
2 270 nt HindIII-SstI probe.
3 242 nt BglII-SstI probe.
4 Protected fragment in the hybridization between the 242 nt BglII-SstI fragment of pIJ702 and mRNA from S. lividans [pIJ702].
The-arrowheads indicate the hybridization bands corresponding to the protected fragments.
FIG. 4 Nucleotide sequence (SEQ ID NO.1) of the DNA region in the mel. cluster that contains the ORF438 indicating its amino acid sequence. The BglII and SStI restriction sites which flank the DNA fragment cloned in pIJ487 to construct pULAD50 are indicated. The two first amino acids of the tyrosinase are also shown.
→Initiation of the mel transcript according to Geistlich et al. (1989) and Leu et al. (1989).
∞→Transcription initiation from Po438 according to S1 nuclease mapping experiments (FIG. 3) rbs, ribosome-binding site.
FIG. 5 Phosphate repression of expression from the Po438 promoter. A neomycin gradient (0-180 ug/ml) was made on solid MM+TES buffer 825 mM, pH 7.2) (upper plate), and on the same medium supplemented with 20 MM sodium phosphate buffer, pH 7.2 (lower plate). Both plates were streaked with a similar amount of S. lividans [pULAD50] spores.
FIG. 6 Calcium induction in Streptomyces of the promoterless XylE gene of Pseudomonas putida when placed downstream of the Po438 promoter. S. lividans [pULAD51] was grown in calcium-free R2YE liquid medium () and R2YE medium supplemented with additional CaCl2 up to 60 mM (66 ). Catechol dioxygenase activity (Cat O2 ase) of S. lividans transformed with pIJ4083 (∘) was not altered when grown in R2YE medium with or without CaCl2.
The work described herein was performed employing the following materials and methods.
Bacterial strains and plasmids. The Streptomyces strains and plasmids used in this study are listed in Table 1.
Media and culture conditions. Transformation of protoplasts Streptomyces strains were grown in R2YE, minimal medium (MM) or YEMEN supplemented with 34% sucrose and 5 mM MgCl2 (Hopwood et al., Genectic manipulation pf Streptomyces. A LABORATORY MANUAL. The John Innes Foundation, Norwich, U.K., 1985). Liquid cultures of Streptomyces were grown in triple baffled flasks at 28° C. in a rotary shaker with an agitation of 220 rpm.
Preparation and transformation of S. lividans protoplasts were as described (Thompson et. al., J. BACTERIOL. 151:668-677, 1982).
DNA isolation, manipulation and DNA sequencing. Plasmid DNA was isolated following the Kieser method (Kieser et el., PLASMID 12:19-36, 1984). Digestions and ligations were monitored by agarose gel electrophoresis. The conditions for digestion with a restriction endonuclease and ligation reactions were those recommended by the manufacturers. Subcloning of DNA fragments was carried out by digesting 1-2, ug of plasmid DNA with adequate restriction enzyme(s) and the reaction products were separated by gel electrophoresis in low melting point agarose (LMPA).
The nucleotide sequence was determined by the chain termination method of Sanger (Sanger et al., PROC. NATL. ACAD. SCI. USA 74:5463-5467, 1977) using M13 clones (Messing et al., NUCL. ACIDS RES. 9:309-321, 1981).
RNA isolation and S1 nuclease mapping. RNA was isolated according to Kirby (Kirby et al. BIOCHEM. J. 104:258-262, 1967) from 50 hour cultures in MM medium. For S1 mapping the DNA probes were end labelled (Maxam and Gilbert, METHODS ENZYMOL. 65:499-560, 1980). RNA (40 ug) was mixed with 105 c.p.m. of [32 p]-end labelled DNA fragment and denatured at 85° C. for 15 mins. (Favalora et el., METHODS ENZYMOL. 65:718-749, 1980). Hybridization was carried out at 60° C. for 3 h, treated with 60 units of S1 nuclease and the S1 digestion product was loaded onto a 7% (w/v) polyacrylamide gel containing 7M urea, and run in parallel with the M13 mp18 phage and the 242 bp BglII-SstI fragment of pIJ702 sequenced by the Sanger method.
Detection of catechol dioxygenase activity. For plate assays, Streptomyces transformant colonies were grown at 28° C. for 3 days and the plates were sprayed with an aqueous solution of 0.5M catechol. For liquid assays, Streptomyces strains were grown at 28° C. 50 ml of R2YE liquid medium without CaCl2 or supplemented with CaCl2 (60 mM). At different times samples were taken and catechol dioxygenase activities were determined as described (Ingram et al., J. BACTERIOL. 171:6617-6624, 1989). Protein concentrations were determined by the Bradford method by using bovine serum albumine as the standard (Bradford, ANAL. BIOCHEM. 72:248-254, 1976).
The following detailed description will illustrate the invention:
Promoter Activity of Po438
The promoter activity of Po438 has been determined through the expression of the aminoglycoside phosphotransferase gene and the catechol dioxygenase gene contained in two different promoter-probe vectors.
Expression of the aminoglycoside phosphotransferase gene. A 242 bp BglII-SstI fragment from pIJ702 plasmid was subcloned into pIJ487 (Ward et al., MOL. GEN. GENET. 203:468-478, 1986), which carried a promoterless aminoglycoside phosphotransferase gene Expression of this gene confers Kanamicin (km) and neomycin resistance to Streptomyces lividans. Plasmid pULAD50 was thus created (FIG. 1). S. Lividans transformed with pULAD50 was able to grow on MM containing more than 150 ug/ml of Km, whereas S. lividans transformed with pIJ487 (promoter-probe vector without inserted promoter) does not grow on MM with 10 ug/ml Km as shown in FIG. 2. This result clearly indicates that the BglII-SstI fragment of pIJ70 has promoter activity in Streptomyces, with orientation from the SStI site to the BglII site.
Expression of the catechol dioxygenase gene. The 242 bpBgl BglII-SstI fragment as in the above example wa subcloned into a different promoter-probe vector, the plasmid pIJ4083 which carried the XylE gene from Pseudomonas putida, coding for the enzyme catechol dioxygenase. The hybrid plasmid was named pULAD51 (FIG. 1). Streptomyces lividans transformed with pULAD51 was grown in R2YE medium supplemented with CaCl2 up to 60 Mm. Quantitation of Catechol dioxygenase activity indicated that Po438 exerts promoter activity also when inserted upstream of the XylE gene (FIG. 6).
Regulation of the Expression from Po438 by Calcium Ions
The effect of different ions on the promoter activity of Po438 has been analyzed. Since the level of Kanamycin resistance is dependent on the amount of salt in the growth medium (Hopwood et al., Genetic Manipulation of Streptomyces. A Laboratory Manual. The John Innes Foundation, Norwich, U.K. 1985), Neomycin (Neo) was used in MM for these studies. In all cases MM was supplemented with TES buffer (25 mM, pH 7.2) in order to avoid pH changes. Mg2+, Fe2+, Zn2+, Cu2+ cations had no effect on the strength of Po438 (resistance to 170 ug/ml Neo on MM plates), whereas several monovalent cations (Na+, K+, Li+, Cs+, 10 mM) exerted a weak reduction of the promoter activity and there was no growth on MM containing more than 100 ug/ml of Neo. A reduction in promoter activity-was also observed when the MM was supplemented with sodium phosphate buffer (20 mM, pH 7.2) as shown in FIG. 5.
Calcium ions positively regulate the promoter activity of Po438. Ca2+ greatly increased Neo resistance of S. lividans transformed with pULAD50 plasmid and a strict correlation between CaCl2 concentration and Neo level restistance has been shown (Table 2).
Plasmid pULAD60 represents an example of a similar plasmid with the same neo-gene linked to a different promoter, the saf promoter, as has been described in WO 90/14426. The Neo resistance of S. lividans transformed with pULAD60 was not, however, modified when growing on MM containing different concentrations of CaCl2 (0, 10, 20, 30, 40 mM), suggesting that there is not a post-translational stimulation of the neo gene product, nor a calcium inactivation of Neomycin. If the effect of Ca2+ were not specific, the stimulating effect should be observed with all the constructions. This demonstrates that the Po438 promoter activity is specifically regulated by calcium ions.
Calcium induction was also observed in the expression of Xyle in S. lividans transformed with plasmid pULAD51 as reported in FIG. 6. Catechol dioxygenase activity (Cat O2 ase) greatly increased when the R2YE culture medium was supplemented with CaCl2 up to a 60 Mm concentration. Catechol dioxygenase activity of S. lividans transformed with pIJ4038 (the promoter-probe vector without the Po438 promoter) was, on the contrary, not altered when grown in R2YE medium with or without calcium chloride.
Determination of the Transcription Start Point in Po438
S1 nuclease mapping experiments were carried out to determine the transcription start point and the sequence of the Po438 promoter. A 270 bp HindIII-SstI fragment isolated from pULAD50 was labelled in the HindIII 5' end and hybridized with mRNA isolated from S. lividans carrying pULAD50. The protected fragment showed in a size of around 24 nt shorter than the control probe (FIG. 3) what situated the transcription start point around the C at 24 nt from the SstI site (FIG. 4), A second S1 nuclease mapping experiment was performed with the original plasmid pIJ702, which also contains the Po438 DNA region. The 242 bp BglII-SstI fragment of pIJ702 was used as a probe. The fragment was labelled in the BglII 5' end and hybridized with mRNA isolated from s. lividans transformed with pIJ702. FIG. 3 shows that the protected fragment was still 24 nt shorter than the probe, indicating that the transcription initiation occurs in pIJ702 in a similar nucleotide as in pULAD50.
FIG. 4 shows the promoter region of the mel gene in ORF 438, located about 30 nt upstream from the start codon of the ORF 438 (Geistlich et. al., Molecular Microbiology 3: 1061-1069, 1989; Leu et al., GENE 84:267-277, 1989) as well as the Po438 promoter located in opposite orientation to that of ORF 438 and its transcription start point according to the S1 nuclease mapping experiments of this work.
While the aminoglycoside phosphtransferase gene and the catechol dioxygenase gene have been specifically exemplified, it should be understood that for the purpose of enhancing expression through the use of the Po438 promoter, the gene for any polypeptide or protein produced by the Streptomyces species being used can be modified by removing the native promoter and substituting the Po438 promoter. Similarly, the foreign DNA coding for a polypeptide or protein can be inserted into any such endogenous gene. Preferably, however, the endogenous gene selected will be one which expresses the protein through the cell wall and into the culture medium, in which case, it is important to retain the secretion signal sequence. The foreign DNA is thus preferably inserted in such a way as to retain the secretion signals as much as possible from the extracellular enzyme gene. While these signals are predominantly on the leader sequence, there is evidence with respect to endogenous genes for extracellular enzymes that the terminal carboxyl end is also important for secretion. Thus, it may be best to create a fusion protein by inserting the foreign DNA into the endogenous DNA, rather than removing the transcriptional part of the endogenous DNA and substituting the foreign DNA.
It should also be understood that the foreign DNA sequence may be any non-Streptomyces-derived DNA sequence encoding a protein or polypeptide, particularly one of eukaryotic or viral origin. Examples of such eukaryotic and viral DNA sequences are sequences encoding human and animal leukocyte interferons (IFN-alpha), fibrobtast interferons (IFN-beta), and immune interferons (IFN-gamma), human insulin, human and animal growth and other hormones, such as corticotropin releasing factor (CRF), human serum albumin and various human blood factors and plasmignogen activators, both tissue and urokinase, hepatitis B viral core and surface antigens, FMD viral antigens and other human animal and viral polypeptides and proteins.
              TABLE 1                                                     
______________________________________                                    
Strains and plasmids                                                      
                             Source of                                    
Designation                                                               
           Relevant characteristics                                       
                             reference                                    
______________________________________                                    
S. lividans JI1326                                                        
           wild type         JI                                           
S. antibiaticus                                                           
ATCC 11891 wild type, melanin producer                                    
                             ATCC                                         
pIJ702     thiostrepton resistance and                                    
                             Katz et al. 1983                             
           melanin.sup.+                                                  
pULAD60    pIJ702 carrying the saf                                        
                             WO 90/14426                                  
           promoter                                                       
pIJ487     promoter-probe vector for                                      
                             Ward et. al. 1986                            
           Strectomyces carrying the                                      
           neo gene as reporter                                           
pULAD50    pIJ487 carrying the 242 bp                                     
                             This work                                    
           SstI-BqlII fragment from                                       
           pIJ702                                                         
pIJ4083    promoter-probe vector for                                      
           Streptomyces carrying the                                      
           XylE gene as reporter                                          
pULAD51    pIJ4083 carrying the 242 bp                                    
                             This work                                    
           SstI-BqlII fragment from                                       
           pIJ702                                                         
______________________________________                                    
 JI, Collection of microorganisms of the John Innes Institute, Colney Lane
 Norwich; NR4UH, UK; ATCC, American Type Culture Collection               
              TABLE 2                                                     
______________________________________                                    
Level of neomycin resistance of S. lividans [pULAD50]                     
growing on solid MM supplemented with CaCl.sub.2                          
CaCl.sub.2 concentration (mM)                                             
                 Neo resistance (μg/ml)                                
______________________________________                                    
 0               180                                                      
10               300                                                      
20               650                                                      
30               1100                                                     
40               1900                                                     
______________________________________                                    
References Quoted in the Figures and Table 1
GEISTLICH M., Irniger S. and Hutter R.: Localization and functional analysis of the regulated promoter from the Streptomyces glaucescens mel operon. Molecular Microbiology. 3 (1989) 1061-1069.
HOPWOOD. D. A.: Genetic analysis and genome structure in Streptomyces coelicolor. Bacterial. Rev. 31 (1967) 373-403.
KATZ, E., Thompson, C. J. and Hopwood, D. A.: Cloning and expression of the tyrosinase gene from Streptomyces antibioticus in Streptomyces lividans. J. Gen. Microbiol. 129 (1983) 2703-2714.
LEU, W. M., Wu, S. Y., Lin, J. J., Lo, S. J. and Wu Lee, Y. M.: Analysis of the promoter region of the melanin locus from Streptomyces antibioticus. Gene 84 (1989) 267-277.
WARD, J. M., Janssen, G. R., Kieser, T., Bibb, M. J., Buttner, M. J. and Bibb, M. J.: Construction and characterization of a series of multi-copy promoter-probe plasmid vectors for Streptomyces using the aminoglycoside phosphotransferase gene from Tn5 as indicator, Mol. Gen. Genet. 203 (1986) 468-478.
__________________________________________________________________________
SEQUENCE LISTING                                                          
(1) GENERAL INFORMATION:                                                  
(iii) NUMBER OF SEQUENCES: 3                                              
(2) INFORMATION FOR SEQ ID NO:1:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 572 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: both                                                    
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: DNA (genomic)                                         
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(ix) FEATURE:                                                             
(A) NAME/KEY: CDS                                                         
(B) LOCATION: 94..531                                                     
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                   
TCGCGGCCAACCGGTCCGGGCCGATTTCTCCCCTTCTCCTCCGGTCGATAGGTATGCGGG60            
GTCGTCAACCCAACGCACCCCAGGAGGTCCCGCATGCCGGAACTCACCCGTCGT114                 
MetProGluLeuThrArgArg                                                     
15                                                                        
CGCGCGCTCGGCGCCGCAGCCGTCGTCGCCGCCGGTGTCCCGCTGGTC162                       
ArgAlaLeuGlyAlaAlaAlaValValAlaAlaGlyValProLeuVal                          
101520                                                                    
GCCCTTCCCGCCGCCCGCGCGGACGATCGGGGGCACCACACCCCCGAG210                       
AlaLeuProAlaAlaArgAlaAspAspArgGlyHisHisThrProGlu                          
253035                                                                    
GTCCCCGGGAACCCGGCCGCGTCCGGCGCCCCCGCCGCCTTCGACGAG258                       
ValProGlyAsnProAlaAlaSerGlyAlaProAlaAlaPheAspGlu                          
40455055                                                                  
ATCTACAAGGGCCGCCGGATACAGGGCCGGACGGTCACCGACGGCGGG306                       
IleTyrLysGlyArgArgIleGlnGlyArgThrValThrAspGlyGly                          
606570                                                                    
GGCCACCACGGCGGCGGTCACGGCGGTGACGGTCACGGCGGCGGCCAT354                       
GlyHisHisGlyGlyGlyHisGlyGlyAspGlyHisGlyGlyGlyHis                          
758085                                                                    
CACGGCGGCGGTTACGCCGTGTTCGTGGACGGCGTCGAACTGCATGTG402                       
HisGlyGlyGlyTyrAlaValPheValAspGlyValGluLeuHisVal                          
9095100                                                                   
ATGCGCAACGCCGACGGCTCGTGGATCAGCGTCGTCAGCCACTACGAG450                       
MetArgAsnAlaAspGlySerTrpIleSerValValSerHisTyrGlu                          
105110115                                                                 
CCGGTGGACACCCCGCGCGCCGCGGCCCGCGCTGCGGTCGACGAGCTC498                       
ProValAspThrProArgAlaAlaAlaArgAlaAlaValAspGluLeu                          
120125130135                                                              
CAGGGCGCCCGGCTCCTCCCCTTCCCCTCCAACTGACCTTCTCCCCCGCACTT551                  
GlnGlyAlaArgLeuLeuProPheProSerAsn                                         
140145                                                                    
TTGGAGCACCCGCACATGACC572                                                  
(2) INFORMATION FOR SEQ ID NO:2:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 146 amino acids                                               
(B) TYPE: amino acid                                                      
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: protein                                               
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                   
MetProGluLeuThrArgArgArgAlaLeuGlyAlaAlaAlaValVal                          
151015                                                                    
AlaAlaGlyValProLeuValAlaLeuProAlaAlaArgAlaAspAsp                          
202530                                                                    
ArgGlyHisHisThrProGluValProGlyAsnProAlaAlaSerGly                          
354045                                                                    
AlaProAlaAlaPheAspGluIleTyrLysGlyArgArgIleGlnGly                          
505560                                                                    
ArgThrValThrAspGlyGlyGlyHisHisGlyGlyGlyHisGlyGly                          
65707580                                                                  
AspGlyHisGlyGlyGlyHisHisGlyGlyGlyTyrAlaValPheVal                          
859095                                                                    
AspGlyValGluLeuHisValMetArgAsnAlaAspGlySerTrpIle                          
100105110                                                                 
SerValValSerHisTyrGluProValAspThrProArgAlaAlaAla                          
115120125                                                                 
ArgAlaAlaValAspGluLeuGlnGlyAlaArgLeuLeuProPhePro                          
130135140                                                                 
SerAsn                                                                    
145                                                                       
(2) INFORMATION FOR SEQ ID NO:3:                                          
(i) SEQUENCE CHARACTERISTICS:                                             
(A) LENGTH: 219 base pairs                                                
(B) TYPE: nucleic acid                                                    
(C) STRANDEDNESS: both                                                    
(D) TOPOLOGY: linear                                                      
(ii) MOLECULE TYPE: DNA (genomic)                                         
(iii) HYPOTHETICAL: NO                                                    
(iv) ANTI-SENSE: NO                                                       
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                                   
CCGCGGCGCGCGGGGTGTCCACCGGCTCGTAGTGGCTGACGACGCTGATCCACGAGCCGT60            
CGGCGTTGCGCATCACATCGAGTTCGACGCCGTCCACGAACACGGCGTAACCGCCGCCGT120           
GATGGCCGCCGCCGTGAGCGTGACCGCCGTGACCGCCGCCGTGGTGGCCCCCGCCGTCGG180           
TGACCGTCCGGCCCTGTATCCGGCGGCCCTTGTAGATCT219                                
__________________________________________________________________________

Claims (3)

We claim:
1. A method of expressing a foreign DNA sequence in Streptomyces comprising operatively linking said foreign DNA sequence to a Streptomyces expression control sequence which comprises the calcium regulated promoter contained in SEQ ID NO:1 or to a fragment thereof having calcium regulated promoter activity.
2. A method in accordance with claim 1 wherein the foreign DNA sequence and Streptomyces expression control sequence are inserted in the chromosomal DNA of the Streptomyces.
3. A method in accordance with claim 1 wherein said foreign DNA sequence is operatively linked to said Streptomyces expression control sequence through a DNA sequence encoding at least a part of the signal sequence of a protein or polypeptide secreted from Streptomyces, said DNA sequence encoding the signal sequence being expressed together with said foreign DNA sequence under the control of said Streptomyces expression control sequence to afford secretion of the protein or polypeptide coded for by the foreign DNA sequence.
US08/264,526 1991-12-12 1994-06-23 P0438, a new calcium-regulated promoter Expired - Fee Related US5660999A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/264,526 US5660999A (en) 1991-12-12 1994-06-23 P0438, a new calcium-regulated promoter

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES9102765 1991-12-12
ES9102765 1991-12-12
US07/989,363 US5385841A (en) 1991-12-12 1992-12-11 PO438, a new calcium-regulated promoter
US08/264,526 US5660999A (en) 1991-12-12 1994-06-23 P0438, a new calcium-regulated promoter

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07/989,363 Continuation US5385841A (en) 1991-12-12 1992-12-11 PO438, a new calcium-regulated promoter

Publications (1)

Publication Number Publication Date
US5660999A true US5660999A (en) 1997-08-26

Family

ID=8274462

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/989,363 Expired - Lifetime US5385841A (en) 1991-12-12 1992-12-11 PO438, a new calcium-regulated promoter
US08/264,526 Expired - Fee Related US5660999A (en) 1991-12-12 1994-06-23 P0438, a new calcium-regulated promoter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07/989,363 Expired - Lifetime US5385841A (en) 1991-12-12 1992-12-11 PO438, a new calcium-regulated promoter

Country Status (15)

Country Link
US (2) US5385841A (en)
EP (1) EP0546833B1 (en)
JP (1) JP3340164B2 (en)
AT (1) ATE154392T1 (en)
AU (1) AU661073B2 (en)
CA (1) CA2084351C (en)
DE (1) DE69220336T2 (en)
DK (1) DK0546833T3 (en)
ES (1) ES2103902T3 (en)
GR (1) GR3024625T3 (en)
IL (1) IL103975A (en)
LT (1) LT3133B (en)
LV (1) LV10728B (en)
RU (1) RU2112802C1 (en)
ZA (1) ZA929284B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6243486B1 (en) 1996-08-30 2001-06-05 Marvin Weiss System for counting colonies of micro-organisms in petri dishes and other culture media

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA929284B (en) * 1991-12-12 1993-06-02 Serono Lab P0438, an new calcium-regulated promoter.

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148552A1 (en) * 1983-06-07 1985-07-17 Biogen, Inc. Streptomyces expression sequence and methods for expressing DNA sequences in streptomyces
US4745056A (en) * 1984-10-23 1988-05-17 Biotechnica International, Inc. Streptomyces secretion vector
US4766066A (en) * 1984-09-27 1988-08-23 Eli Lilly And Company Method of using bacteriophage lambda p1 promoter to produce a functional polypeptide in streptomyces
WO1988007079A1 (en) * 1987-03-09 1988-09-22 Cetus Corporation Expression of heterologous genes in streptomyces species
WO1990014426A2 (en) * 1989-05-19 1990-11-29 Applied Research Systems Ars Holding N.V. Saf polypeptide, gene, promoter and use for expression in streptomyces
US5200327A (en) * 1985-11-06 1993-04-06 Cangene Corporation Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
US5385841A (en) * 1991-12-12 1995-01-31 Laboratorios Serono S.A. PO438, a new calcium-regulated promoter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3536182A1 (en) * 1985-10-10 1987-04-16 Hoechst Ag PROMOTOR ARRANGEMENT FOR STREPTOMYCETE VECTORS

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148552A1 (en) * 1983-06-07 1985-07-17 Biogen, Inc. Streptomyces expression sequence and methods for expressing DNA sequences in streptomyces
US4766066A (en) * 1984-09-27 1988-08-23 Eli Lilly And Company Method of using bacteriophage lambda p1 promoter to produce a functional polypeptide in streptomyces
US4745056A (en) * 1984-10-23 1988-05-17 Biotechnica International, Inc. Streptomyces secretion vector
US5200327A (en) * 1985-11-06 1993-04-06 Cangene Corporation Expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces
WO1988007079A1 (en) * 1987-03-09 1988-09-22 Cetus Corporation Expression of heterologous genes in streptomyces species
WO1990014426A2 (en) * 1989-05-19 1990-11-29 Applied Research Systems Ars Holding N.V. Saf polypeptide, gene, promoter and use for expression in streptomyces
US5385841A (en) * 1991-12-12 1995-01-31 Laboratorios Serono S.A. PO438, a new calcium-regulated promoter

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Bernan et al. 1985 Gene 87:101 110. *
Bernan et al. 1985 Gene 87:101-110.
E. Katz et al., "Cloning and expression of the tyrosinase gene from Streptomyces antibioticus in Streptomyces limidans", J. Gen. Microbiol. (1983) 129:2703:2714.
E. Katz et al., Cloning and expression of the tyrosinase gene from Streptomyces antibioticus in Streptomyces limidans , J. Gen. Microbiol. (1983) 129:2703:2714. *
J.M. Ward et al., "Construction and charicterisation of a series of multi-copy promoter-probe plasmid vectors for Streptomyces using the aminoglyco-side phosphotransferase gene from Tn5 as indicator", Mol. Gen. Genet. (1986) 203:468-478.
J.M. Ward et al., Construction and charicterisation of a series of multi copy promoter probe plasmid vectors for Streptomyces using the aminoglyco side phosphotransferase gene from Tn5 as indicator , Mol. Gen. Genet. (1986) 203:468 478. *
M. Geistlich et al., "Localization and functional analysis of the regulated promoter from the Streptomyces glaucescens mel operon", Cell (1989) 3:1061-1069.
M. Geistlich et al., Localization and functional analysis of the regulated promoter from the Streptomyces glaucescens mel operon , Cell (1989) 3:1061 1069. *
W. M. Leu et al., Analysis of the promoter region of the melanin locus from Streptomyces antibioticus , Gene (1989) 84:267 277. *
W.-M. Leu et al., "Analysis of the promoter region of the melanin locus from Streptomyces antibioticus", Gene (1989) 84:267-277.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6243486B1 (en) 1996-08-30 2001-06-05 Marvin Weiss System for counting colonies of micro-organisms in petri dishes and other culture media

Also Published As

Publication number Publication date
ES2103902T3 (en) 1997-10-01
US5385841A (en) 1995-01-31
GR3024625T3 (en) 1997-12-31
AU661073B2 (en) 1995-07-13
JPH05336972A (en) 1993-12-21
EP0546833B1 (en) 1997-06-11
DE69220336D1 (en) 1997-07-17
EP0546833A3 (en) 1994-04-06
LV10728A (en) 1995-06-20
JP3340164B2 (en) 2002-11-05
LV10728B (en) 1995-12-20
DK0546833T3 (en) 1997-09-15
IL103975A (en) 1998-08-16
AU2979192A (en) 1993-06-17
LTIP237A (en) 1994-07-15
DE69220336T2 (en) 1997-09-25
RU2112802C1 (en) 1998-06-10
CA2084351A1 (en) 1993-06-13
ZA929284B (en) 1993-06-02
LT3133B (en) 1995-01-31
IL103975A0 (en) 1993-05-13
ATE154392T1 (en) 1997-06-15
EP0546833A2 (en) 1993-06-16
CA2084351C (en) 2007-04-10

Similar Documents

Publication Publication Date Title
Ramón et al. Cloning and characterization of the isopenicillin N synthetase gene mediating the formation of the β-lactam ring in Aspergillus nidulans
Gilbert et al. Production and secretion of proteins by streptomycetes
Lawlor et al. Pleiotropic morphological and antibiotic deficiencies result from mutations in a gene encoding a tRNA-like product in Streptomyces coelicolor A3 (2).
Neal et al. Nucleotide sequence analysis reveals similarities between proteins determining methylenomycin A resistance in Streptomyces and tetracycline resistance in eubacteria
Steiert et al. A Gene Coding for a Membrane–Bound Hydrolase is Expressed as a Secreted, Soluble Enzyme in Streptomyces Lividans
JPH09107981A (en) Use of phosphinotrisyn-resistant gene
Li et al. Cloning, purification, and properties of a phosphotyrosine protein phosphatase from Streptomyces coelicolor A3 (2)
Sakurada et al. Cloning, expression, and characterization of the Micromonospora viridifaciens neuraminidase gene in Streptomyces lividans
Junji et al. Cloning and sequencing of the aculeacin A acylase-encoding gene from Actinoplanes utahensis and expression in Streptomyces lividans
EP0429600B1 (en) Saf polypeptide, gene, promoter and use for expression in streptomyces
US5660999A (en) P0438, a new calcium-regulated promoter
CN111117942A (en) Genetic engineering bacterium for producing lincomycin and construction method and application thereof
EP0498827B1 (en) Improved plasmid vectors for cellular slime moulds of the genus dictyostelium
Murai et al. A novel insertion sequence (IS)-like element of the thermophilic bacterium PS3 promotes expression of the alanine carrier protein-encoding gene
Inokoshi et al. Efficient production of aculeacin A acylase in recombinant Streptomyces strains
US5122595A (en) SAF polypeptide gene coding therefor, and SAF promoter
EP0759474B1 (en) A regulatory factor involved in expression of nitrilase gene, and its gene
US7718396B2 (en) Inducible high expression system
US20040086962A1 (en) Methods and materials relating to gene expression
RU2221868C2 (en) Gene encoding l-asparaginase in erwinia carotovora and strain escherichia coli vkpm = b-8174 as producer of erwinia caratovora l-asparaginase
US4865982A (en) Cloned streptomycete gene
WO1986000929A1 (en) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
JPH07222587A (en) New cephalosporin c acylase and its production
US5766881A (en) Induction-free process for the recombinant preparation of glutarylamidase
JP3330670B2 (en) Alkene monooxygenase, gene encoding the same, transformed microorganism and alkene epoxidation method

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20090826